A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence
CONCLUSION: Chemotherapy-related ADRs among cancer patients are worrisome. It has a negative impact on patient quality of life and in addition increases cost of therapy. It is found that timely reporting of chemotherapy-related ADRs and having an effective ADR monitoring system in place ensure preventability of the ADRs in many cases. Oncologists, Radiotherapists and Onco-surgeons should be actively involved in ADR reporting (Onco-Pharmacovigilance) and exchange constructive information, update and educate each other about appropriate use of anticancer drugs. Onco-pharmacovigilance is the need of the hour and could be of immense value in reducing morbidity and mortality if practiced with utmost importance.
Source: Indian Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Pramod Kumar Sharma Arup Kumar Misra Ajay Gupta Surjit Singh Puneet Dhamija Puneet Pareek Source Type: research
More News: Alopecia | Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Education | India Health | International Medicine & Public Health | Skin | Statistics | Study | WHO